Teratogenesis and immunosuppressive treatment

Transplantation Proceedings

Volumn 36, Issue 3, 2004, Pages 705-707

  Danesi, R ^a   Del Tacca, M ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

BIRTH DEFECT; BLOOD PLACENTA BARRIER; BREAST FEEDING; BREAST MILK; CONCEPTION; CONFERENCE PAPER; CONGENITAL MALFORMATION; DIABETES MELLITUS; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG EXCRETION; DRUG EXPOSURE; DRUG FATALITY; DRUG SAFETY; EMBRYOTOXICITY; FETUS DISEASE; FETUS MALFORMATION; FETUS RESORPTION; FOOD AND DRUG ADMINISTRATION; GRAFT FAILURE; GRAFT REJECTION; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LOW BIRTH WEIGHT; LOW DRUG DOSE; MAINTENANCE THERAPY; MOTHER; NEPHROTOXICITY; NONHUMAN; OSTEOPOROSIS; PERMEABILITY BARRIER; PLACENTA; POPULATION; POSTOPERATIVE PERIOD; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; RECIPIENT; RISK; TERATOGENESIS; TOXICITY; TRANSPLANTATION; VASCULARIZATION;

ABNORMALITIES, DRUG-INDUCED; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SAFETY; TERATOGENS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 2042472183     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.03.017     Document Type: Conference Paper

References (11)

1. Audus K.L. Controlling drug delivery across the placenta. Eur J Pharm Sci. 8:1999;161
2. Armenti V.T., Moritz M.J., Cardonick E.H., et al. Immunosuppression in pregnancy. Choices for infant and maternal health. Drugs. 62:2002;2361
3. Finnel R.H. Teratology general considerations and principles. J Allergy Clin Immunol. 103:1999;S337
4. Fraser F.C., Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology. 51:1995;45
5. Friedman J.M., Polifka J.E. The effects of drugs on the fetus and nursing infant a handbook for health care professionals. 1996;Johns Hopkins University Press, Baltimore
6. Farley D.E., Shelby J., Alexander D., et al. The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. Transplantation. 52:1991;106
7. Jain A., Venkataramanan R., Fung J.J., et al. Pregnancy after liver transplantation under tacrolimus. Transplantation. 64:1997;559
8. American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics. 93:1994;137
9. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant. 17:(Suppl 4):2002;50
10. Thiagarajan K.D., Easterling T., Davis C., et al. Breast-feeding by a cyclosporine-treated mother. Obstet Gynecol. 97:2001;816
11. French A.E., Soldin S.J., Soldin O.P., et al. Milk transfer and neonatal safety of tacrolimus. Ann Pharmacother. 37:2003;815